MicroRNAs in cancer and cardiovascular disease

M Ilieva, R Panella, S Uchida - Cells, 2022 - mdpi.com
Although cardiac tumor formation is rare, accumulating evidence suggests that the two
leading causes of deaths, cancers, and cardiovascular diseases are similar in terms of …

Established and Emerging Cancer Therapies and Cardiovascular System: Focus on Hypertension—Mechanisms and Mitigation

LE Butel-Simoes, TJ Haw, T Williams, S Sritharan… - …, 2023 - Am Heart Assoc
Cardiovascular disease and cancer are 2 of the leading causes of death worldwide.
Although improvements in outcomes have been noted for both disease entities, the success …

Biomimetic platelet-camouflaged drug-loaded polypyrrole for the precise targeted antithrombotic therapy

Z Zhao, X Li, Y Wang, C Liu, G Ling… - Journal of …, 2023 - Springer
Lower extremity deep venous thrombosis (LEDVT) affects patient's quality of life for a long
time, and even causes pulmonary embolism, which threatens human health. Current …

DoxoDB: A Database for the Expression Analysis of Doxorubicin-Induced LncRNA Genes

R Distefano, M Ilieva, JH Madsen, S Rennie, S Uchida - Non-coding RNA, 2023 - mdpi.com
Cancer and cardiovascular disease are the leading causes of death worldwide. Recent
evidence suggests that these two life-threatening diseases share several features in disease …

In Vitro Evaluation of Ferutinin Rich-Ferula communis L., ssp. glauca, Root Extract on Doxorubicin-Induced Cardiotoxicity: Antioxidant Properties and Cell Cycle …

R Macrì, I Bava, F Scarano, R Mollace… - International Journal of …, 2023 - mdpi.com
The clinical use of anthracycline Doxorubicin as an antineoplastic drug in cancer therapy is
limited by cardiotoxic effects that can lead to congestive heart failure. Recent studies have …

[HTML][HTML] Social determinants of health in cardio-oncology: multi-level strategies to overcome disparities in care: JACC: CardioOncology state-of-the-art review

FO Baah, S Sharda, K Davidow, S Jackson… - JACC …, 2024 - Elsevier
Addressing the need for more equitable cardio-oncology care requires attention to existing
disparities in cardio-oncologic disease prevention and outcomes. This is particularly …

[HTML][HTML] Activated fibroblasts in cardiac and cancer fibrosis: An overview of analogies and new potential therapeutic options

G Nicolini, S Balzan, F Forini - Life Sciences, 2023 - Elsevier
Heart disease and cancer are two major causes of morbidity and mortality in the
industrialized countries, and their increasingly recognized connections are shifting the focus …

Malignant Neoplasms Arising in the Cardiac Pacemaker Cavity: A Systematic Review

FCA Moraes, L Dal Moro, FR Pessoa, ESR Passos… - Cancers, 2023 - mdpi.com
Simple Summary Cancer, a complex group of diseases marked by abnormal cell
proliferation and loss of physiological functions. Furthermore, tumors in the cardiac …

From beats to metabolism: the heart at the core of interorgan metabolic cross talk

R Romero-Becera, AM Santamans, AC Arcones… - …, 2024 - journals.physiology.org
The heart, once considered a mere blood pump, is now recognized as a multifunctional
metabolic and endocrine organ. Its function is tightly regulated by various metabolic …

Cardio-oncoimmunology: cardiac toxicity, cardiovascular hypersensitivity, and Kounis syndrome

NG Kounis, MY Hung, C de Gregorio, V Mplani… - Life, 2024 - mdpi.com
Cancer therapy can result in acute cardiac events, such as coronary artery spasm, acute
myocardial infarction, thromboembolism, myocarditis, bradycardia, tachyarrhythmias, atrio …